Loading...
Recombinant Immunotoxin with T Cell Epitope Mutations that Greatly Reduce Immunogenicity for Treatment of Mesothelin Expressing Tumors
SS1P is a recombinant immunotoxin (RIT) that targets mesothelin. It consists of an anti-mesothelin Fv fused to a portion of Pseudomonas exotoxin A. In clinical studies it has produced dramatic responses in patients with advanced mesothelioma, when combined with immunosuppressive therapy so that seve...
Na minha lista:
| Udgivet i: | Mol Cancer Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674367/ https://ncbi.nlm.nih.gov/pubmed/26443804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0532 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|